Literature DB >> 27490391

Integrative Modeling Strategies for Predicting Drug Toxicities at the eTOX Project.

Ferran Sanz1, Pau Carrió1, Oriol López1, Luigi Capoferri2, Derk P Kooi2, Nico P E Vermeulen2, Daan P Geerke2, Floriane Montanari3, Gerhard F Ecker3, Christof H Schwab4, Thomas Kleinöder4, Tomasz Magdziarz4, Manuel Pastor5.   

Abstract

Early prediction of safety issues in drug development is at the same time highly desirable and highly challenging. Recent advances emphasize the importance of understanding the whole chain of causal events leading to observable toxic outcomes. Here we describe an integrative modeling strategy based on these ideas that guided the design of eTOXsys, the prediction system used by the eTOX project. Essentially, eTOXsys consists of a central server that marshals requests to a collection of independent prediction models and offers a single user interface to the whole system. Every of such model lives in a self-contained virtual machine easy to maintain and install. All models produce toxicity-relevant predictions on their own but the results of some can be further integrated and upgrade its scale, yielding in vivo toxicity predictions. Technical aspects related with model implementation, maintenance and documentation are also discussed here. Finally, the kind of models currently implemented in eTOXsys is illustrated presenting three example models making use of diverse methodology (3D-QSAR and decision trees, Molecular Dynamics simulations and Linear Interaction Energy theory, and fingerprint-based QSAR).
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  AOP; Drug safety; Integrative modeling; Multi-scale models; Toxicity prediction

Mesh:

Year:  2015        PMID: 27490391     DOI: 10.1002/minf.201400193

Source DB:  PubMed          Journal:  Mol Inform        ISSN: 1868-1743            Impact factor:   3.353


  6 in total

Review 1.  Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction.

Authors:  Antonio Segovia-Zafra; Daniel E Di Zeo-Sánchez; Carlos López-Gómez; Zeus Pérez-Valdés; Eduardo García-Fuentes; Raúl J Andrade; M Isabel Lucena; Marina Villanueva-Paz
Journal:  Acta Pharm Sin B       Date:  2021-11-18       Impact factor: 11.413

Review 2.  Computational Toxicology Methods in Chemical Library Design and High-Throughput Screening Hit Validation.

Authors:  Kirk E Hevener
Journal:  Methods Mol Biol       Date:  2018

3.  Generating Modeling Data From Repeat-Dose Toxicity Reports.

Authors:  Oriol López-Massaguer; Kevin Pinto-Gil; Ferran Sanz; Alexander Amberg; Lennart T Anger; Manuela Stolte; Carlo Ravagli; Philippe Marc; Manuel Pastor
Journal:  Toxicol Sci       Date:  2018-03-01       Impact factor: 4.849

4.  Subtle Structural Differences Trigger Inhibitory Activity of Propafenone Analogues at the Two Polyspecific ABC Transporters: P-Glycoprotein (P-gp) and Breast Cancer Resistance Protein (BCRP).

Authors:  Theresa Schwarz; Floriane Montanari; Anna Cseke; Katrin Wlcek; Lene Visvader; Sarah Palme; Peter Chiba; Karl Kuchler; Ernst Urban; Gerhard F Ecker
Journal:  ChemMedChem       Date:  2016-03-10       Impact factor: 3.466

5.  Development of an Infrastructure for the Prediction of Biological Endpoints in Industrial Environments. Lessons Learned at the eTOX Project.

Authors:  Manuel Pastor; Jordi Quintana; Ferran Sanz
Journal:  Front Pharmacol       Date:  2018-10-11       Impact factor: 5.810

6.  The eTRANSAFE Project on Translational Safety Assessment through Integrative Knowledge Management: Achievements and Perspectives.

Authors:  François Pognan; Thomas Steger-Hartmann; Carlos Díaz; Niklas Blomberg; Frank Bringezu; Katharine Briggs; Giulia Callegaro; Salvador Capella-Gutierrez; Emilio Centeno; Javier Corvi; Philip Drew; William C Drewe; José M Fernández; Laura I Furlong; Emre Guney; Jan A Kors; Miguel Angel Mayer; Manuel Pastor; Janet Piñero; Juan Manuel Ramírez-Anguita; Francesco Ronzano; Philip Rowell; Josep Saüch-Pitarch; Alfonso Valencia; Bob van de Water; Johan van der Lei; Erik van Mulligen; Ferran Sanz
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.